Loading clinical trials...
Loading clinical trials...
Effect of Testofen on Erectile Function in an Adult Male Population - A Double Blind, Randomised Controlled Trial.
This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.
Age
40 - 75 years
Sex
MALE
Healthy Volunteers
No
RDC Clinical Pty Ltd
Brisbane, Queensland, Australia
Start Date
April 19, 2022
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
July 24, 2025
120
ESTIMATED participants
Testofen 300mg
DRUG
Testofen 600mg
DRUG
Placebo comparator
DRUG
Lead Sponsor
RDC Clinical Pty Ltd
NCT07480161
NCT07460960
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07431008